THE success of chronic hemodialysis in terminal renal failure depends on repeated access to blood vessels that will provide a continuous flow of up to 250 to 300 ml. per minute. A technic was ...

Purpose. The feasibility of using a limitedsampling algorithm for administration of vancomycin for treatment of vascular-access-related bacteremia in outpatient high flux hemodialysis was ...

The LifeSite Hemodialysis System (Vasca, Inc., Tewksbury, MA, USA)is totally subcutaneous, incorporating two silicone catheters positioned in the central venous system and connected to a stainless ...

A 25-year-old woman with vitiligo universalis, a severe form of vitiligo that causes nearly complete loss of skin color ...

The Department of Health (DOH) has recommended updating the Philippine Health Insurance Corporation's (PhilHealth) package ...

BEVERLY, Mass., Nov. 4, 2024 /PRNewswire/ -- Award-winning medical technology innovator, Quanta Dialysis Technologies®, has confirmed the US Food and Drug Administration (FDA) has given 510(k ...

Quanta Dialysis Technologies has raised $60 million to expand its U.S. commercial presence for its Quanta dialysis system.

Event: Piper Sandler 36th Annual Healthcare Conference Location: The Lotte New York Palace, NY Presentation: Thursday, December 5, 8:00 a.m. EST Webcast: https://event.webcasts.com/ A replay will be ...